METAvivor Research and Support, Inc

Patients will join with METAvivor to launch an ambitious advocacy agenda to help increase funding for research and to advocate for access to care for people with Stage IV, metastatic cancer

METAvivor will train stage IV metastatic breast cancer patients and their supporters from across the US on advocacy issues affecting this community.

METAvivor Research and Support, Inc. is requesting proposals for metastatic breast cancer research and has increased grant awards to $200,000 for this grant cycle.

METAvivor Research and Support announces that Patrick Quinn and Pamela King have joined our Board of Directors, and the organization has a new slate of officers.

METAvivor Research and Support announces seven new grant awards for metastatic breast cancer research. The 2016 grant awards hold promise for clinical trials that may have a significant and positive impact for metastatic cancer.

Inspired by the Cancer Moonshot and in collaboration with the Metastasis Research Society, METAvivor commits to funding $1 million in metastasis research grants in 2017, and doubling that amount in 2018.

METAvivor will partner with breast cancer organizations to launch an ambitious advocacy agenda to help increase funding for research and to improve access to social services for people with Stage IV, metastatic cancer.

METAvivor Research and Support Inc., a non-profit organization dedicated to funding research for Stage IV metastatic breast cancer, announced that it has hired Sonya Negley as its first ever Executive Director.

The organization funds $1 Million in grants for research into Stage IV breast cancer

Swimming quest across country to raise research money specifically for fighting terminal breast cancers